Stem Cells Morph into Blood Vessels via Epigenetic Modification – Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News |
Stem Cells Morph into Blood Vessels via Epigenetic Modification
Genetic Engineering & Biotechnology News Scientists at the University of Illinois at Chicago have identified a molecular mechanism that directs embryonic stem cells to mature into endothelial cells that form blood vessels. Understanding the processes initiated by this mechanism could help … Researchers uncover epigenetic switches that turn stem cells into blood vessel …Phys.Org Researchers Uncover Epigenetic Switches that Turn Stem Cells into Blood …Bioscience Technology |
Smarter Analyst |
Preclinical Data On Neuralstem’s Genetically Modified HK532-IGF-1 Stem Cells …
PR Newswire (press release) GERMANTOWN, Md., June 26, 2015 /PRNewswire/ — Neuralstem, Inc. (NYSE MKT: CUR), a biopharmaceutical company using neural stem cell technology to develop small molecule and cell therapy treatments for central nervous system diseases, … Company Update (NYSE MKT:CUR): Preclinical Data On Neuralstem, Inc.’s …Smarter Analyst Neuralstem up 11% premarket on preclinical Alzheimer’s data (CUR)Seeking Alpha Short Interest in Neuralstem Drops By 5.6% (CUR)WKRB News |
|
Becky Sheaves – Your stem cell donations could save someone’s life
Western Morning News Then it is just a case of sitting quietly while a line goes into one arm, removes some blood and stem cells, and then the blood is put back into your other arm via another line. You can even read The Western Morning News as it happens. But you will be … |
|
Becky Sheaves – Your stem cell donations could save someone’s life
Western Morning News Then it is just a case of sitting quietly while a line goes into one arm, removes some blood and stem cells, and then the blood is put back into your other arm via another line. You can even read The Western Morning News as it happens. But you will be … |
New York Post |
Condé Nast loses longtime p.r. pro to stem cell foundation
New York Post Condé Nast’s longtime top p.r. pro Maurie Perl has landed a new full time gig as senior VP communications and marketing of the New York Stem Cell Foundation, reporting to its CEO and co-founder, Susan Solomon. “I start now, effective immediately,” said … |